Company
LivaNova
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
12
510(k), De Novo and PMA
Device trials
40
As lead sponsor, any status
Adverse event reports
1,364
Received Nov 1, 2025 to Nov 20, 2026
Recall records
76
One per recalled product
LivaNova is on our public-company list (ticker LIVN). Names searched as well: Cyberonics. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
LIVN
Nasdaq · LivaNova PLC
Public float
$2.50B
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$1.39B
Fiscal year ending Dec 31, 2025
Net income
-$242M
Fiscal year ending Dec 31, 2025
R&D spending
$186M
Fiscal year ending Dec 31, 2025
Cash
$563M
As of Sep 30, 2026
Long-term debt
$295M
As of Sep 30, 2026
Shares outstanding
55.1M
As of Oct 28, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2024 | – | – | $336M | – |
| 2023 | – | – | $50.0M | – |
| 2022 | – | – | $508M | – |
| 2021 | – | $323M | – | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
The 8 newest of 12 since 2015.
P250013 · Decided Mar 18, 2026 · 327 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
- Venous Return Cannulae510(k)
K250937 · Decided Mar 11, 2026 · 348 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K250283 · Decided Jul 10, 2025 · 160 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
9 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT03887715 · 6,800 participants (planned) · Start Sep 26, 2019 · Primary completion Feb 28, 2028
Device: Vagus Nerve Stimulation (VNS) · For: Treatment Resistant Depression
Sites: Birmingham, Alabama; Huntsville, Alabama; Burlingame, California · 101 sites in all
NCT03320304 · 500 participants (planned) · Start Dec 14, 2017 · Primary completion Dec 1, 2029
Device: Vagal Nerve Simulation (VNS) Therapy · For: Treatment Resistant Depression
Sites: Vienna, Austria; Leuven, Belgium; Bamberg, Germany · 18 sites in all
- Treating Obstructive Sleep Apnea Using Targeted Hypoglossal NeurostimulationPivotal-lookingCompleted
NCT04950894 · 107 participants · Start Feb 24, 2022 · Primary completion Oct 17, 2024
Device: Hypoglossal Nerve Stimulation · For: Obstructive Sleep Apnea; OSA; Apnea and 4 more
Sites: Birmingham, Alabama; Tucson, Arizona; Roseville, California · 19 sites in all
37 more trials with a free account
Reports received
1,364
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1,018
75% of reports
Injury reports
308
23% of reports
Death reports
38
2.8% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 161 | 105 | 10 | 0 |
| Jan 24 | 98 | 32 | 8 | 0 |
| Feb 24 | 155 | 52 | 10 | 0 |
| Mar 24 | 122 | 52 | 8 | 0 |
| Apr 24 | 102 | 69 | 5 | 0 |
| May 24 | 131 | 56 | 8 | 0 |
| Jun 24 | 133 | 55 | 9 | 0 |
| Jul 24 | 147 | 60 | 18 | 0 |
| Aug 24 | 142 | 44 | 5 | 0 |
| Sep 24 | 113 | 55 | 12 | 1 |
| Oct 24 | 135 | 69 | 3 | 0 |
| Nov 24 | 125 | 63 | 4 | 0 |
| Dec 24 | 130 | 44 | 6 | 0 |
| Jan 25 | 89 | 48 | 3 | 0 |
| Feb 25 | 120 | 53 | 9 | 0 |
| Mar 25 | 130 | 51 | 6 | 0 |
| Apr 25 | 141 | 45 | 9 | 0 |
| May 25 | 114 | 43 | 4 | 0 |
| Jun 25 | 105 | 33 | 5 | 0 |
| Jul 25 | 102 | 25 | 1 | 0 |
| Aug 25 | 86 | 22 | 4 | 0 |
| Sep 25 | 86 | 20 | 7 | 0 |
| Oct 25 | 138 | 29 | 7 | 0 |
| Nov 25 | 114 | 24 | 3 | 0 |
| Dec 25 | 115 | 36 | 4 | 0 |
| Jan 26 | 53 | 39 | 2 | 0 |
| Feb 26 | 71 | 18 | 4 | 0 |
| Mar 26 | 98 | 32 | 6 | 0 |
| Apr 26 | 83 | 32 | 2 | 0 |
| May 26 | 70 | 29 | 4 | 0 |
| Jun 26 | 75 | 18 | 0 | 0 |
| Jul 26 | 96 | 21 | 4 | 0 |
| Aug 26 | 74 | 18 | 2 | 0 |
| Sep 26 | 78 | 30 | 4 | 0 |
| Oct 26 | 91 | 11 | 3 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1067-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Z-1068-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
- SenTiva, REF: 1000; SenTiva Duo, REF: 1000-D; Generators Part of the VNS Therapy System. Used for Vagus Nerve Stimulation (VNS).Open, Classified
Z-1072-2025 · Started Dec 12, 2024 · Posted by FDA Jan 31, 2025
Reason given: Vagus nerve stimulator generators may stop delivering stimulation due to an internal, mechanically activated component that may become stuck in a closed position, which may result in patients returning to baseline seizure frequency or depressive symptoms and in the longer term, patients may be required to undergo...
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
73 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.